Rare Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are older than 16 years old and have been diagnosed with Adult-onset Still's Disease using recognised medical diagnostic guidelines (confirm with trial site)
- You are 16 years old or younger and have been diagnosed with the systemic form of Juvenile Idiopathic Arthritis (a type of childhood arthritis affecting the whole body) using recognised 2001 medical criteria
- You (or your legal guardian, if you are a minor or a protected adult) have agreed and signed a form consenting to take part in the study and allowing your health information to be collected
- You are enrolled in the French national health insurance system ("Régime National d'Assurance Maladie")
Who may not be able to join:
- You have recurring fevers caused by an infection (such as tuberculosis, toxoplasmosis, deep abscesses, viral infections, or blood poisoning) or a tumour (such as lymphoma)
- You have another clearly defined inflammatory joint condition, such as rheumatoid arthritis, psoriatic arthritis, or spondyloarthropathy
- You have an autoimmune or inflammatory condition such as lupus, sarcoidosis, Blau syndrome, Behçet's disease, vasculitis, polymyositis, or dermatomyositis
- You have a well-defined inherited inflammatory condition with a confirmed genetic mutation, such as familial Mediterranean fever, cryopyrinopathies, TRAPS, or mevalonate kinase deficiency
- You have a known genetic form of a serious complication called Macrophage Activation Syndrome
- You are unable to understand the study information or sign the consent form
- You are not enrolled in the French national health insurance system ("Régime National d'Assurance Maladie")
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sophie Georgin-Lavialle, PHD, INSERM U933
Phone: 0033 156017447
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
General signs of the disease; Clinical signs of the disease; Biological results; - The impact of the disease on the patient's daily life
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.